Got $5,000? This Is the No. 1 Semiconductor Stock to Buy Before Earnings Season Really Gets Going

TSMC reported first-quarter 2026 revenue of about $36 billion, up 35% year over year, with March revenue surging 45% as AI demand remains exceptionally strong. Management expects 2026 capex of $52 billion to $56 billion, up from $40.9 billion in 2025, with 70% to 80% directed toward 3nm and 2nm nodes and CoWoS packaging capacity expanding rapidly. Geopolitical and supply-chain risks remain, but the article argues the stock still looks attractive at 30x earnings versus a semiconductor median near 39x.

Analysis

The key market implication is not simply that TSMC is growing, but that the AI capex cycle is becoming more front-loaded and bottlenecked by advanced packaging rather than wafer starts. That shifts value capture away from the chip designers alone and toward the toll collectors with scarce capacity, which should keep pricing power elevated even if end-demand growth moderates. In other words, the bottleneck is moving downstream in the supply chain, and that tends to lengthen the duration of the earnings upgrade cycle for the entire AI hardware stack.

The second-order effect is that accelerated 2nm/advanced packaging investment is a signal that customers are reserving capacity further out, which usually precedes another round of estimate revisions for NVDA, AMD, and select networking names. However, the broader beneficiary set is narrower than the headline implies: if CoWoS remains the constraining node, then the market may overprice “AI semis” generically while underpricing the few firms with verifiable supply access. That creates a clean relative-value setup versus less capacity-constrained names that depend on the same narrative but lack the same leverage to the bottleneck.

The main risk is not demand collapse in the next quarter; it is margin dilution and operational friction over the next 2-3 quarters as the company spends aggressively to add capacity while managing a more complex geopolitical and logistics footprint. If input disruptions or export restrictions tighten, the market may start to discount a higher cost base before revenue inflects fully into profits. So near term, the thesis is “revenue beats persist,” but the stock’s next leg depends on whether operating leverage survives the capex surge.

Consensus appears to be underappreciating how much of this move is a supply-chain pricing event rather than a pure end-demand story. That matters because supply-constrained cycles can stay strong longer than expected, but they also become more fragile to any failure in execution. The upside case remains intact, but the trade is increasingly about owning the scarce enablers and avoiding crowded secondaries that will not see the same bottleneck-driven economics.

Key Decisions for Investors

• Long TSM into the April 16 earnings release, using a 1-3 month horizon; upside is continued estimate revisions and packaging scarcity persistence, but trim into any post-print gap if management commentary signals margin drag from accelerated capex.
• Pair long TSM / short a basket of less supply-constrained AI hardware names over the next 2-3 months; the thesis is that scarce advanced-node and packaging capacity will capture more of the incremental dollar than commoditized exposure.
• Add selective long exposure to NVDA on pullbacks, but prefer TSM as the cleaner bottleneck beneficiary; if TSM confirms tighter capacity and stronger capex, NVDA should benefit via supply assurance, though with more valuation sensitivity.
• Use call spreads on TSM rather than outright stock for the next earnings window; this preserves upside to a demand-confirmation beat while limiting downside if the market focuses on capex intensity or geopolitical risk.
• Avoid chasing broad semiconductor ETFs at current levels; the risk/reward is inferior to single-name exposure because the cycle is being driven by scarce nodes, not uniform industry demand.